The @AstraZeneca company had to conduct new Phase 3 trials to garner possible approval from @US_FDA & results are just out, via press release:
- "79% #vaccine efficacy at preventing symptomatic #COVID19
- 100% efficacy against severe disease & hospit."
astrazeneca.com
- "79% #vaccine efficacy at preventing symptomatic #COVID19
- 100% efficacy against severe disease & hospit."
astrazeneca.com
More
@AstraZeneca says there were no racial or ethnic diffs in #vaccine response (but 79% of test subjs were Caucasian)
"The vaccine was well tolerated...no safety concerns...no increased risk of thrombosis or events characterised by thrombosis among the 21,583 participants" MORE
@AstraZeneca says there were no racial or ethnic diffs in #vaccine response (but 79% of test subjs were Caucasian)
"The vaccine was well tolerated...no safety concerns...no increased risk of thrombosis or events characterised by thrombosis among the 21,583 participants" MORE
3/@AstraZeneca
"The #vaccine can be stored, transported and handled at normal refrigerated conditions (2-8 degrees Celsius or 36-46 degrees Fahrenheit) for at least six months and administered without the need for preparation within existing healthcare settings."
MORE #COVID19
"The #vaccine can be stored, transported and handled at normal refrigerated conditions (2-8 degrees Celsius or 36-46 degrees Fahrenheit) for at least six months and administered without the need for preparation within existing healthcare settings."
MORE #COVID19
4/Funded by US taxpayers:
"In May 2020, @AstraZeneca received support of more than $1bn from @BARDA for the development, production & delivery of the vaccine under an agreement with the US Department of Defense..."
#COVID19
"In May 2020, @AstraZeneca received support of more than $1bn from @BARDA for the development, production & delivery of the vaccine under an agreement with the US Department of Defense..."
#COVID19
• • •
Missing some Tweet in this thread? You can try to
force a refresh
